Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)]

Post Date

May 19th 2010

Application Due Date

November 29th 2010

Funding Opportunity Number

RFA-DK-10-008

CFDA Number(s)

93.847
93.865

Funding Instrument Type(s)

Grant

Funding Activity Categories

Food and Nutrition
Health
Income Security and Social Services

Eligibility Categories

Small Businesses

Funding

• Estimated Total Funding:

  $3200000

• Award Range:

  $None - $None

Grant Description

Purpose. This FOA solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward an integrated long term glucose regulated insulin delivery system (artificial pancreas). Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 5-10 projects awarded as a result of this announcement is $ 3.2M for fiscal year 2011. Future year amounts will depend on annual appropriations.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-10-008.html